ABL Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Abbott Laboratories

Watchlist Manager

Watchlist

Price: 105.82 EUR

Market Cap: €187.1B

A	Abbott Laboratories XBER:ABL	US
H	Healthcare Trust Of America Inc F:HT01	US
M	Medtronic PLC XMUN:2M6	IE
	AxoGen Inc F:LT3	US
	Frontdoor Inc NASDAQ:FTDR	US
M	MSA Safety Inc F:M07	US
	First Commonwealth Financial Corp NYSE:FCF	US
E	Estrima SpA MIL:BIRO	IT
	Banco de Sabadell SA OTC:BNDSF	ES
L	Lindsay Corp SWB:LMF	US
	FibroGen Inc NASDAQ:FGEN	US

Profitability Summary

Abbott Laboratories's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

57%

Strong 3Y Average Gross Margin

56%

Gross Margin is Increasing

55% > 57%

Healthy Operating Margin

17%

Sustainable 3Y Average Operating Margin

17%

Operating Margin is Increasing

16% > 17%

Healthy Net Margin

12%

Sustainable 3Y Average Net Margin

20%

Declining Net Margin

13% > 12%

Exceptional Free Cash Flow Margin

17%

Strong 3Y Average Free Cash Flow Margin

15%

Free Cash Flow Margin is Increasing

14% > 17%

Positive ROE

11%

Positive 3Y Average ROE

Positive 3Y Average ROIC

13%

Declining ROIC

9% > 7%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.